PULMONARY EMBOLISM ACUTE MASSIVE
Clinical trials for PULMONARY EMBOLISM ACUTE MASSIVE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY EMBOLISM ACUTE MASSIVE trials appear
Sign up with your email to follow new studies for PULMONARY EMBOLISM ACUTE MASSIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial aims to stop deadly blood clots with quick catheter action
Disease control Recruiting nowThis study tests whether using a catheter to break up or remove blood clots early, along with standard care, can save more lives in people with a massive pulmonary embolism. About 210 participants will be randomly assigned to receive either catheter treatment within 60 minutes pl…
Matched conditions: PULMONARY EMBOLISM ACUTE MASSIVE
Phase: NA • Sponsor: Leipzig Heart Science gGmbH • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New registry to test Clot-Busting injection for severe lung clots
Disease control Recruiting nowThis registry is studying a drug called non-immunogenic staphylokinase (Fortelyzin®) given as a single injection to dissolve blood clots in the lungs. It will include up to 20,000 adults with massive pulmonary embolism who are already receiving the drug in routine care. The goal …
Matched conditions: PULMONARY EMBOLISM ACUTE MASSIVE
Sponsor: Supergene, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC